Purpose of the Procedure
- Non-invasive assessment of the gastric mucosa status.
- Early detection of chronic atrophic gastritis.
- Identifying individuals at high risk for gastric adenocarcinoma.
Book Pepsinogen Panel in Saudi Arabia | Lahalak Medical Platform
Protect your health with our Serum Pepsinogen Panel. This essential screening detects gastric atrophy and assesses stomach cancer risks early, providing vital insights for prevention and timely medical intervention.
Scientific name: Serum Pepsinogen Panel (PGI/PGII) for Gastric Cancer Risk
A blood test measuring Pepsinogen I and II levels to evaluate gastric mucosal health and identify chronic atrophy or conditions predisposing to gastric adenocarcinoma risk.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
8-12 hours fasting
Included Services
- Blood sample collection
- Pepsinogen I level measurement
- Pepsinogen II level measurement
- PGI/PGII Ratio calculation
Medical Service Information
Who Should Get Tested?
- Individuals with a family history of stomach cancer.
- Patients suffering from chronic gastritis or H. pylori infections.
- Individuals over 40 years old for routine preventive screening.
Clinical Significance
- Low PGI levels or a low PGI/PGII ratio indicate gastric atrophy.
- Normal results suggest a lower probability of pre-cancerous changes.
- Results should be reviewed by a gastroenterologist for further diagnostic steps like endoscopy if needed.
Conditions & Notices
- Fasting for 8 to 12 hours is required before the test
- Inform the doctor about any gastric medications being taken
Medical services you might also like
